ロード中...
Prospective Immune Dynamics during the First 24 Weeks of Efavirenz Based-Antiretroviral Therapy in HIV-1-Infected Subjects, According to CD4(+) T-Cell Counts at Presentation: The IMMUNEF Clinical Trial
BACKGROUND: Longitudinal characterization of immune recovery in the first-phase of antiretroviral therapy (ART) is poorly described. We compared immune kinetics in individuals who were diagnosed early or late with HIV-1 infection, (thus commencing ART with different CD4(+) T-cell counts), in order t...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324909/ https://ncbi.nlm.nih.gov/pubmed/25671649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0117118 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|